Frontiers Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy

The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures

Frontiers A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer

Cancers, Free Full-Text

Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma

Cancers, Free Full-Text

Cancers, Free Full-Text

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

IJMS, Free Full-Text

Frontiers Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes

IJMS, Free Full-Text

Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma [PeerJ]

Frontiers Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters

Frontiers Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer